Vistin Pharma ASA: Invitation to Q2 2023 conference call
August 16 2023 - 6:00AM
Vistin Pharma ASA: Invitation to Q2 2023 conference call
Oslo, Norway, 16 August 2023
Vistin Pharma ASA will release its second quarter and YTD 2023
results on Wednesday 23rd of August 2023. Vistin Pharma will
host a conference call for all shareholders and interested parties
at the same day; Wednesday 23rd of August at 08:30 CET.
There will be a Q&A session following the management
discussion.
The conference call will be held in English.
The second quarter conference call will be available via
web and audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/jokra7jp
Telephone conference
(online
registration):
https://register.vevent.com/register/BI6600178838a944b187ed120748334f53
*****
For further information, please contact:
Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing
Metformin Hydrochloride (API). The Metformin is also available as
Direct Compressible lubricated granules. As a solely dedicated
European Metformin producer, Vistin Pharma is a well-positioned
supplier to leading pharmaceutical companies. Vistin Pharma is
headquartered in Oslo, Norway, and has highly qualified employees
and a dedicated manufacturing facility in Kragerø.
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Jul 2023 to Jul 2024